跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,417 条关于
“GRI Bio”
全部
10,417
临床试验
6,515
药物
1,576
机构
317
资讯
2,009
去年
GRI Bio Advances Phase 2a Trial of GRI-0621 for Idiopathic Pulmonary Fibrosis with Promising Interim Safety Data
9个月前
GRI Bio's GRI-0621 Shows Promise in Phase 2a IPF Trial with Disease-Modifying Potential
7个月前
GRI Bio Secures Patent Protection for Novel NKT Cell-Targeting Compounds Across Inflammatory Diseases
3个月前
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
去年
Antifibrotic Drug Development Gains Momentum with $3B+ in Deals and Breakthrough Clinical Results
去年
AI-Driven Drug ISM001-055 Shows Promise in Phase IIa Trial for Idiopathic Pulmonary Fibrosis
去年
STGen Bio's Songdo Plant Secures FDA cGMP Approval, Expanding Global Reach
去年
Tolerance Bio Partners with ZipCode Bio to Develop Targeted Thymus Therapeutics for Immune Aging
去年
Mabwell and Aditum Bio Launch Kalexo Bio to Advance Novel siRNA Therapy for Cardiovascular Disease
去年
Passage Bio's PBFT02 Shows Promise in Frontotemporal Dementia Trial
第 1 页,共 201 页
上一页
下一页